WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies

Phase 1

Recruiting

Conditions: Pediatric Hematologic Malignancies

Interventions: Device: Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs Plus

First Posted Date: 2021-08-18

Last Posted Date: 2024-03-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 32

Registration Number: NCT05011422

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC

Phase 2

Withdrawn

Conditions: Non-small Cell Lung Cancer
NSCLC
Non-small Cell Carcinoma
Non Small Cell Lung Cancer

Interventions: Drug: Ramucirumab
Drug: Atezolizumab
Drug: N-803

First Posted Date: 2021-08-16

Last Posted Date: 2021-11-05

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT05007769

Testing the Decision Aid: Supporting Patient Decisions About Upper Extremity Surgery in Cervical SCI

Not Applicable

Completed

Conditions: Cervical Spinal Cord Injury
Tetraplegia

Interventions: Other: Surveys for Research Purposes

First Posted Date: 2021-08-09

Last Posted Date: 2022-08-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT04995796

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

Not Applicable

Recruiting

Conditions: Whole Genome Sequencing
Myelodysplastic Syndromes
Acute Myeloid Leukemia

Interventions: Device: ChromoSeq

First Posted Date: 2021-08-03

Last Posted Date: 2024-10-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 275

Registration Number: NCT04986657

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Systematic Quality Improvement With Realtime Event Support

Not Applicable

Completed

Conditions: Telemedicine

Interventions: Other: Telemedicine intervention

First Posted Date: 2021-07-30

Last Posted Date: 2023-04-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 25506

Registration Number: NCT04983329

Locations: 🇺🇸
Washington University School of Medicine/Barnes Jewish Hospital, Saint Louis, Missouri, United States

Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks

Recruiting

Conditions: Glioma

Interventions: Device: RS-fMRI

First Posted Date: 2021-07-23

Last Posted Date: 2024-01-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 96

Registration Number: NCT04975139

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

Not Applicable

Recruiting

Conditions: Breast Cancer
Cancer of the Breast

Interventions: Device: DiviTum® TKa assay
Other: Study Care Plans

First Posted Date: 2021-07-20

Last Posted Date: 2024-06-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 55

Registration Number: NCT04968964

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

Phase 3

Recruiting

Conditions: HPV-unrelated Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Palbociclib
Drug: Cetuximab

First Posted Date: 2021-07-19

Last Posted Date: 2024-10-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 81

Registration Number: NCT04966481

Locations: 🇺🇸
Saint Luke's Hospital, Kansas City, Missouri, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Understanding Host-pathogen Interaction in the Respiratory Mucosa During Pregnancy

Active, not recruiting

Conditions: Pregnancy Related
Innate Inflammatory Response

Interventions: Other: Nasal brush sampling

First Posted Date: 2021-07-15

Last Posted Date: 2024-03-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 30

Registration Number: NCT04962477

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

GNAO1 Natural History Study

Conditions: GNAO1

First Posted Date: 2021-07-06

Last Posted Date: 2021-07-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 50

Registration Number: NCT04950946

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy